David N. Rider

1.8k total citations
38 papers, 783 citations indexed

About

David N. Rider is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, David N. Rider has authored 38 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Genetics. Recurrent topics in David N. Rider's work include Epigenetics and DNA Methylation (6 papers), Genetic Associations and Epidemiology (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). David N. Rider is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Genetic Associations and Epidemiology (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). David N. Rider collaborates with scholars based in United States, South Korea and Australia. David N. Rider's co-authors include Ellen L. Goode, Julie M. Cunningham, Mariza de Andrade, Sebastian M. Armasu, Joanna M. Biernacka, Robert A. Vierkant, Brooke L. Fridley, Zachary S. Fredericksen, Tanya M. Petterson and William R. Bamlet and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

David N. Rider

38 papers receiving 771 citations

Peers

Countries citing papers authored by David N. Rider

Since Specialization

Citations

This map shows the geographic impact of David N. Rider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Rider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Rider more than expected).

Fields of papers citing papers by David N. Rider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Rider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Rider. The network helps show where David N. Rider may publish in the future.

Co-authorship network of co-authors of David N. Rider

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Rider. A scholar is included among the top collaborators of David N. Rider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Rider. David N. Rider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Erica J. Childs, Kari G. Chaffee, Steven Gallinger, Sapna Syngal, Ann G. Schwartz, Michele L. Coté, Melissa L. Bondy, Ralph H. Hruban, Stephen J. Chanock, Robert N. Hoover, Charles S. Fuchs, David N. Rider, Laufey T. Ámundadóttir, Rachael Z. Stolzenberg‐Solomon, Brian M. Wolpin, Harvey A. Risch, Michael Goggins, Gloria M. Petersen, Alison P. Klein	22
2	The association of copy number variation and percent mammographic density 2015 ·BMC Research Notes ·Elizabeth J. Atkinson, Jeanette E. Eckel‐Passow, Alice Wang, Alexandra J. Greenberg, Christopher G. Scott, V. Shane Pankratz, Kristen S. Purrington, Thomas A. Sellers, David N. Rider, John A. Heit, Mariza de Andrade, Julie M. Cunningham, Fergus J. Couch, Celine M. Vachon	2
3	Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome 2014 ·BMC Medical Genomics ·Brooke L. Fridley, Sebastian M. Armasu, Mine Cicek, Melissa C. Larson, Chen Wang, Stacey J. Winham, Kimberly R. Kalli, Devin C. Koestler, David N. Rider, Viji Shridhar, Janet E. Olson, Julie M. Cunningham, Ellen L. Goode	22
4	The Association of Telomere Length with Colorectal Cancer Differs by the Age of Cancer Onset 2014 ·Clinical and Translational Gastroenterology ·Lisa A. Boardman, Kristin Litzelman, Songwon Seo, Ruth Johnson, (unknown), Grace W. Kimmel, Julie M. Cunningham, Ronald E. Gangnon, Corinne D. Engelman, Douglas L. Riegert‐Johnson, John D. Potter, Robert W. Haile, Daniel D. Buchanan, Mark A. Jenkins, David N. Rider, Stephen N. Thibodeau, Gloria M. Petersen, Halcyon G. Skinner	22
5	Correlation of Chromosomal Instability, Telomere Length and Telomere Maintenance in Microsatellite Stable Rectal Cancer: A Molecular Subclass of Rectal Cancer 2013 ·PLoS ONE ·Lisa A. Boardman, Ruth Johnson, Kimberly Viker, (unknown), Robert B. Jenkins, Douglas L. Riegert‐Johnson, Thomas C. Smyrk, Kristin Litzelman, Songwon Seo, Ronald E. Gangnon, Corinne D. Engelman, David N. Rider, (unknown), Stephen N. Thibodeau, Gloria M. Petersen, Halcyon G. Skinner	30
6	Genetic susceptibility loci, environmental exposures, and Parkinson's disease: A case–control study of gene–environment interactions 2013 ·Parkinsonism & Related Disorders ·Sun Ju Chung, Sebastian M. Armasu, Kari J. Anderson, Joanna M. Biernacka, Timothy G. Lesnick, David N. Rider, Julie M. Cunningham, J. Eric Ahlskog, Roberta Frigerio, Demetrius M. Maraganore	22
7	Genomic determinants of motor and cognitive outcomes in Parkinson’s disease 2012 ·Parkinsonism & Related Disorders ·Sun Ju Chung, Sebastian M. Armasu, Joanna M. Biernacka, Kari J. Anderson, Timothy G. Lesnick, David N. Rider, Julie M. Cunningham, J. Eric Ahlskog, Roberta Frigerio, Demetrius M. Maraganore	22
8	Germline Predictors of Androgen Deprivation Therapy Response in Advanced Prostate Cancer 2012 ·Mayo Clinic Proceedings ·Manish Kohli, Shaun M. Riska, Douglas W. Mahoney, High Seng Chai, David W. Hillman, David N. Rider, Brian A. Costello, Rui Qin, Jatinder K. Lamba, Deepak M. Sahasrabudhe, James R. Cerhan	24
9	Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer 2011 ·Cancer Causes & Control ·(unknown), David N. Rider, Kimberly R. Kalli, Keith L. Knutson, Gail P. Jarvik, Ellen L. Goode	24
10	Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism 2011 ·Journal of Thrombosis and Haemostasis ·John A. Heit, J. M. Cunningham, Tanya M. Petterson, Sebastian M. Armasu, David N. Rider, Mariza de Andrade	57
11	Inherited Determinants of Ovarian Cancer Survival 2010 ·Clinical Cancer Research ·Ellen L. Goode, Matthew J. Maurer, Thomas A. Sellers, Catherine M. Phelan, Kimberly R. Kalli, Brooke L. Fridley, Robert A. Vierkant, (unknown), Karen L. White, Gary L. Keeney, William A. Cliby, David N. Rider, Linda E. Kelemen, Monica B. Jones, Prema P. Peethambaram, Jonathan Lancaster, Janet E. Olson, Joellen M. Schildkraut, Julie M. Cunningham, Lynn C. Hartmann	44
12	Polymorphic Variants in Hereditary Pancreatic Cancer Genes Are Not Associated with Pancreatic Cancer Risk 2009 ·Cancer Epidemiology Biomarkers & Prevention ·Robert R. McWilliams, William R. Bamlet, Mariza de Andrade, David N. Rider, Fergus J. Couch, Julie M. Cunningham, Martha Matsumoto, Kari G. Rabe, (unknown), Gloria M. Petersen	5
13	Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer 2009 ·BMC Cancer ·(unknown), Robert A. Vierkant, Catherine M. Phelan, Brooke L. Fridley, S. Keith Anderson, Keith L. Knutson, Joellen M. Schildkraut, Julie M. Cunningham, Linda E. Kelemen, V. Shane Pankratz, David N. Rider, Mark Liebow, Lynn C. Hartmann, Thomas A. Sellers, Ellen L. Goode	17
14	Assessment of genotype imputation methods 2009 ·BMC Proceedings ·Joanna M. Biernacka, Rui Tang, Jia Li, Shannon K. McDonnell, Kari G. Rabe, Jason P. Sinnwell, David N. Rider, Mariza de Andrade, Ellen L. Goode, Brooke L. Fridley	26
15	Single versus multiple imputation for genotypic data 2009 ·BMC Proceedings ·Brooke L. Fridley, Shannon K. McDonnell, Kari G. Rabe, (unknown), Joanna M. Biernacka, Jason P. Sinnwell, David N. Rider, Ellen L. Goode	2
16	Identification of genes and haplotypes that predict rheumatoid arthritis using random forests 2009 ·BMC Proceedings ·Rui Tang, Jason P. Sinnwell, Jia Li, David N. Rider, Mariza de Andrade, Joanna M. Biernacka	27
17	Polymorphisms in the FGF2 Gene and Risk of Serous Ovarian Cancer: Results From the Ovarian Cancer Association Consortium 2009 ·Twin Research and Human Genetics ·Sharon E. Johnatty, Jonathan Beesley, Xiaohong Chen, Amanda B. Spurdle, Anna DeFazio, Penelope M. Webb, (unknown), (unknown), Ellen L. Goode, David N. Rider, Robert A. Vierkant, S. Keith Anderson, Anna H. Wu, Malcolm C. Pike, David Van Den Berg, Kirsten B. Moysich, Roberta B. Ness, Jennifer A. Doherty, (unknown), Celeste Leigh Pearce, Georgia Chenevix‐Trench	7
18	Genetic Variation in the One-Carbon Transfer Pathway and Ovarian Cancer Risk 2008 ·Cancer Research ·Linda E. Kelemen, Thomas A. Sellers, Joellen M. Schildkraut, Julie M. Cunningham, Robert A. Vierkant, V. Shane Pankratz, Zachary S. Fredericksen, (unknown), David N. Rider, Mark Liebow, Ellen L. Goode	50
19	Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies 2008 ·Breast Cancer Research ·Linda E. Kelemen, Fergus J. Couch, Shahana Ahmed, Alison M. Dunning, Paul D.P. Pharoah, Douglas F. Easton, Zachary S. Fredericksen, Robert A. Vierkant, V. Shane Pankratz, Ellen L. Goode, Christopher G. Scott, David N. Rider, Xianshu Wang, James R. Cerhan, Celine M. Vachon	40
20	Inherited variation in carcinogen-metabolizing enzymes and risk of colorectal polyps 2006 ·Carcinogenesis ·Ellen L. Goode, John D. Potter, William R. Bamlet, David N. Rider, Jeanette Bigler	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact